IRB Infra Q3 consolidated net profit up 28% (YoY)
IRB Infrastructure Developers has announced the following results for the quarter ended December 31, 2015 (YOY)
IRB Infrastructure Ltd Q3FY2016 result – Higher execution boosts earnings
The consolidated revenues for the quarter grew by 38.3% YoY to Rs1, 333.3 crore on the back of over 65%YoY growth in construction income.
Standalone
The Company has posted a net profit of Rs108.26 crore Vs Rs15.84 crore.
Total Income increased from Rs920.95 crore Vs Rs508.48 crore.
UPL Q3 consolidated net profit up 15%
UPL has announced the following Q3 results for the quarter ended December 31, 2015
Standalone
Net Profit rose by 45.87% to Rs42.94 crore Vs Rs79.33 crore.
Total Income increased by 9.14% to Rs1411.93 crore Vs Rs1293.61 crore.
Dr Reddy receives USFDA approval for Zembrace SymTouch
Dr Reddy receives USFDA approval for Zembrace SymTouch (sumatriptan succinate) injection for acute treatment of migraines in adults – Positive
DRL receives USFDA nod for Zembrace SymTouch (sumatriptan succinate) injection, a drug-device combination product intended for treatment of acute migraine episodes in adults.
NTPC Q3: Net Profit At Rs2493 Cr
NTPC Q3: Net Profit At Rs2493 Cr
Total Income At Rs17,413
Deferred Tax At Rs485.3 Cr Vs Rs65.7 Cr (YoY)
EBITDA At Rs4,624 Cr
EBITDA Margin At 26.6%
Other Income At Rs244.7 Cr Vs Rs514 Cr (YoY)
Siemens Q1: Net Profit at Rs114 Cr
Siemens Q1: Net Profit at Rs114 Cr
Total Income at Rs2, 314 Cr
Trans & Distribution, Rail Contribute Significantly To Order Intake
Order Intake Increased By 65%.
Read our more services below: